Pathophysiology and Risk Stratification of Sudden Cardiac Death in Ischemic Heart Disease

Nabil El-Sherif, Mohamed Boutjdir, Gioia Turitto

Abstract


Sudden cardiac death accounts for approximately 360,000 annually in the United States and is the cause of half of all cardiovascular deaths. Ischemic heart disease is the major cause of death in the general adult population. Sudden cardiac death can be due to arrhythmic or non-arrhythmic cardiac causes, for example, myocardial rupture. Arrhythmic sudden cardiac death may be caused by ventricular tachyarrhythmia (ventricular tachycardia/ventricular fibrillation) or pulseless electrical activity/asystole. The majority of research in risk stratification centers on ventricular tachyarrhythmias simply because of the availability of a successful management strategy, the implantable cardioverter/ defibrillator. Currently the main criterion of primary defibrillator prophylaxis is the presence of organic heart disease and depressed left ventricular systolic function assessed as left ventricular ejection fraction. However, only one third of eligible patients benefit from the implantable defibrillator, resulting in significant redundancy in the use of the device. The cost to the health care system of sustaining this approach is substantial. Further, the current low implantation rate among eligible population probably reflects a perceived low benefit-to-cost ratio of the device. Therefore, attempts to optimize the selection process for primary implantable defibrillator prophylaxis are paramount. The present report will review the most recent pathophysiology and risk stratification strategies for sudden cardiac death beyond the single criterion of depressed ejection fraction. Emphasis will be placed on electrophysiological surrogates of conduction disorder, dispersion of repolarization, and autonomic imbalance, which represent our current understanding of the electrophysiological mechanisms that underlie the initiation of ventricular tachyarrhythmias. Further, factors that modify arrhythmic death, including noninvasive risk variables, biomarkers, and genomics will be addressed. These factors may have great utility in predicting sudden cardiac arrhythmic death in the general public.


Full Text:

 Subscribers Only

References


Mozaffarian D, Anker SD, Anand I, et al. Prediction of mode of death in heart failure: The Seattle Heart Failure Model. Circulation 2007;116:392-398.

American Heart Association 2001. Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001.

Braunwald E: Shattuck Lecture. Cardiovascular medicine at the turn of the millennium: Triumphs, concerns and opportunities. N Engl J Med 1997;377:1360-1369.

Newby KH, Thompson T, Stebbins A, et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcome. The GUSTO Investigators. Circulation 1998;98:2567-2573.

Jabbari R, Risgaard B, Fosbol EL, et al. Factors associated with and outcomes after ventricular fibrillation before and during primary angioplasty in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2015;116:678-685.

Al-Khatib SM, Granger CB, Huang Y, et al. Sustained ventricular arrhythmias among patients with acute coronary syndrome with no-ST segment elevation: incidence, predictors, and outcomes. Circulation 2002;106:309-312.

Pouleur AC, Barkoudah E, Uno H, et al. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597-602.

Jackowski C, Schwendener N, Grabherr S, et al. Post-mortem cardiac 3-T magnetic resonance imaging visualization of sudden cardiac death? J Am Coll Cardiol 2013;62:617-629.

Wellens HJ, Schwartz PJ, Lindemans FW, et al. Risk stratification of sudden cardiac death: current status and challenges for the future. Eur Heart J 2014;35:1642-1651.

Spooner PM, Albert C, Benjamin EL, et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart Lung, and Blood Institute Workshop, part I. Circulation 2001;103:2361-2364.

Spooner PM, Albert C, Benjamin EL, et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute Workshop, part II. Circulation 2001;103:2447-2452.

Gnasso A, Motti C, Irace C. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 2000;20:1600-1605.

Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517-2522.

Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094.

Nakayama M,Yasue H,Yoshimura M, et al. T786→C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864-2870.

Wang XL, Sim AS,Wang MX, Murrell GA, Trudinger B,Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000;471:45-50.

Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002;105:2595-2599.

St John Sutton MG, Sharpe N: Left ventricular remodeling after myocardial infarction. Pathophysiology and Therapy. Circulation 2000; 101: 2981-2988.

Qin D, Zang ZH, Caref EB, Boutjdir M, Jain P, El-Sherif N. Cellular and ionic basis of arrhythmias in post infarction remodeled ventricular myocardium. Circ Res 1996;79: 461-473.

Gidh-Jain M, Huang B, Jain P, El-Sherif N. Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res. 1996; 79: 669-675.

El-Sherif N, Turitto G. Risk stratification and management of sudden cardiac death: A new paradigm. J Cardiovasc Eletrophysiol 2003; 14:1-7.

Hefti MA, Harder BA, Eppenberger HM, Schaub MC: Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 1997; 29: 2873-2892.

Deng L, Huang B, Qin D, Ganguly K, El-Sherif N. Calcineurin inhibition ameliorates structural, contractile, and electrophysiological consequences of post-infarction remodeling. J Cardiovasc Electrophysiol 2001;12:1055-1061.

El-Adawi H, Deng L, Tramontano A, et al. The functional role of the JAK-STAT pathway in post infarction remodeling. Cardiovasc Res 2003;58:126-135.

Deyell, MW, et al. Sudden cardiac death risk stratification. Circ Res 2015;116: 1907-1918.

Exner DV, Kavanagh KM, Slawnych MP, et al. for the REFINE Investigators.

Noninvasive risk assessment early after a myocardial infarction: the REFINE study. J Am Coll Cardiol. 2007;50:2275–2284.

Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, et al. Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction study group. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart

J. 2009;30:689–698.

Aro AL, Anttonen O, Tikkanen JT, et al. Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population. Circulation 2011;124:704-710.

Kurl S, Makikallio TH, Rautaharju P, et al. Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men. Circulation 2012;125:2588-2594.

Chatterjee S, Changawala N. Fragmented QRS complex: a novel marker of cardiovascular disease. Clinical Cardiol 2010;38:68-71.

Das MK, Maskoun W, Shen C, et al. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 2010;7:74–80.

Steinberg JS, Berbari EJ. The signal-averaaged electrocardiogram: Update on clinical application. J Cardiovasc Electrophysiol 1996;7:972-988.

El-Sherif N, Ursell SN, Bekheit S, et al. Pronostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period. Am Heart J 1989;118:256-264.

Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association; American College of Cardiology Foundation; Heart Rhythm Society; American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology

and Prevention. J Am Coll Cardiol. 2008;52:1179–1199.

van der Bijl, P., Delgado V, Bax JJ, et al. Noninvasive imaging markers associated with sudden cardiac death. Trends Cardiovasc Med 2016;26:348-360.

Perez-David E, Arenal A, Rubio-Guivernau JL, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57:184–194.

Roes SD, Borleffs CJ, van der Geest RJ, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defbrillator. Circ Cardiovasc Imaging. 2009;2:183–190.

Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-2014.

Piccirillo G, Magri D, Matera S, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. Eur Heart J 2007; 28:1344-1350.

Shenthar, J., Deora S, Rai M, et al. Prolonged Tpeak-end and Tpeak-end/QT ratio as predictors of malignant ventricular arrhythmias in the acute phase of ST-segment elevation myocardial infarction: a prospective case-control study. Heart Rhythm 2015;12:484-489.

Behr E, Ensam B. New approaches to predicting the risk of sudden death. Clin Med 2016; 16:283-289.

Haissaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008;358:2016-2023.

Patel RB, Ilkhanoff I, Ng J, et al. Clinical characteristics and prevalence of early repolarization associated with ventricular arrhythmias following acute ST-elevation myocardial infarction. Am J Cardiol;110:615-620.

Rudic B, Veltmann C, Kuntz E, et al. Early repolarization pattern is associated with ventricular fibrillation in patients with acute myocardial infarction. Heart Rhythm 2012;9:1295-1230.

Gold MR, Ip JH, Costantini O, et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008;118:2022-2028.

Costantini O, Hohnloser SH, Kirk MM, et al. ABCD Trial Investigators.

The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 2009;53:471-479.

Verrier RL, Klingenheben T, Malik M, et al. Microvolt T-wave alternans: physiological basis, methods of assessment, and clinical utility-consensus guideline by International Society of Holter and Noninvasive Electrocardiology. J Am Coll Cardiol.2011;58:1309-1324.

Jouven X, Zureik M, Desnos M, et al. Resting heart rate as a predictive risk factor for sudden death in middle aged men. Cardiovasc Res 2001;50:373-378.

Singh JP, Larson MG, O’Donnell CJ, et al. Heritability of heart rate variability: The Framingham Heart Study. Circulation 1999;99:2251-2254.

Muller JE. Circadian variation and triggering of acute coronary events. Am Heart J 1999;137(Pt 2):51-58.

Jaillon P, Simon T. Genetic polymorphism of beta-adrenergic receptors and mortality in ischemic heart disease. Therapie 2007;62:1-7.

Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden cardiac death in the population. Circulation 2001;104:756-761.

Critchley HD, Taggart P, Sutton PM, et al. Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism. Brain 2005;128:75-85.

Gauthier C, Tavernier G, Charpentier F, et al. Functional beta3-adrenergic receptors in the human heart. J Clin Invest 1996;98:556-562.

Vadim VF, Ilya TL. Is beta3-adrenergic receptors a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death. Heart Rhythm 2008;5:298-299.

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology

and the North American Society of Pacing and Electrophysiology.

Circulation. 1996;93:1043–65.

La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–570.

Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular pre-mature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353:1390–1396.

Jacobson, A F, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-2221.

Boogers MJ, Borleffs CJ, Henneman MM, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-2777.

Fallavollita J A, Heavey BM, Luisi AJ, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141-149.

Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome

after myocardial infarction in patients with frequent or repetitive ventricular

premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial

Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675–682.

Hohnloser SH, Kuck KH, Dorian P, et al. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defbrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488.

Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–1890. 66.

Gatzoulis KA, Tsiachris D, Arsenos P, et al. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study. Eur heart J 2019;40:2940-9.

Velasquez A, Goldberger JJ. Risk stratification for sudden cardiac death: show me the money! Eur heart J 2019;40:2950-2.

Cheng A, Zhang Y, Blasco-Colmenares E., et al. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). Circ Arrhythm Electrophysiol 2014;7:1084-1091.

Friedlander Y, Siscovick DS, Weinmann S, et al . Family history as a risk factor for primary cardiac arrest. Circulation 1998;97:155-160.

Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: The Paris Prospective Study I. Circulation 1999;99:1978-1983.

Dekker LR. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006; 114:1140-1145.

Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701.

Glinge C, Sattler S, Jabbari R, et al. Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction. J Geriatr Cardiol 2016;13:789-797.

Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.

Hernesneimi JA, Lyytikkainen L-P, Oksala N, et al. Predicting sudden cardiac death using common genetic risk variants for coronary artery disease. Eur Heart J 2015;36:1669-1675.

Buxton AE, Waks JW, Shen C, et al. Risk stratification for sudden cardiac death in North America-current perspectives. J Electrocardiol 2016;49:817-823.

Borleffs CJ, Wilde AA, Cramer MJ, et al. Clinical implementation of guidelines for cardioverter-defibrillator implantation: lost in translation? Neth Heart J 2007;15:129-132.

Goldberger I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-296.




DOI: http://dx.doi.org/10.18103/imr.v6i5.892

Refbacks

  • There are currently no refbacks.
Copyright 2016. All rights reserved.